Roberto Angioli, MD
Roberto Angioli, MD
Full Professor of Obstetrics and Gynecology
University Campus Bio-Medico of Rome
Via Alvaro del Portillo n. 200
Rome
Italy
00128
Papers:
274
Predicting overall survival in patients with ovarian cancer: a new clinical model
356
Neratinib, an irreversible pan-ErbB receptor inhibitor, is highly effective against primary cervical cancer cell lines harboring HER2/neu gene mutations